Your browser doesn't support javascript.
loading
Power calculations for cluster randomized trials (CRTs) with right-truncated Poisson-distributed outcomes: a motivating example from a malaria vector control trial.
Mwandigha, Lazaro M; Fraser, Keith J; Racine-Poon, Amy; Mouksassi, Mohamad-Samer; Ghani, Azra C.
Afiliación
  • Mwandigha LM; Department of Infectious Disease Epidemiology, MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Fraser KJ; Department of Infectious Disease Epidemiology, MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Racine-Poon A; Department of Statistical Methodology and Consulting, Novartis Pharma AG, Basel, Switzerland.
  • Mouksassi MS; Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Ghani AC; Bill & Melinda Gates Foundation, Seattle, WA, USA.
Int J Epidemiol ; 49(3): 954-962, 2020 06 01.
Article en En | MEDLINE | ID: mdl-32011684
BACKGROUND: Cluster randomized trials (CRTs) are increasingly used to study the efficacy of interventions targeted at the population level. Formulae exist to calculate sample sizes for CRTs, but they assume that the domain of the outcomes being considered covers the full range of values of the considered distribution. This assumption is frequently incorrect in epidemiological trials in which counts of infection episodes are right-truncated due to practical constraints on the number of times a person can be tested. METHODS: Motivated by a malaria vector control trial with right-truncated Poisson-distributed outcomes, we investigated the effect of right-truncation on power using Monte Carlo simulations. RESULTS: The results demonstrate that the adverse impact of right-truncation is directly proportional to the magnitude of the event rate, λ, with calculations of power being overestimated in instances where right-truncation was not accounted for. The severity of the adverse impact of right-truncation on power was more pronounced when the number of clusters was ≤30 but decreased the further the right-truncation point was from zero. CONCLUSIONS: Potential right-truncation should always be accounted for in the calculation of sample size requirements at the study design stage.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ensayos Clínicos Controlados Aleatorios como Asunto Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Int J Epidemiol Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ensayos Clínicos Controlados Aleatorios como Asunto Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Int J Epidemiol Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido